Treatment of recurrent mandibular ameloblastoma.

Abstract

Ameloblastoma is a locally invasive benign odontogenic tumor with a high rate of recurrence in the long term. The authors conducted a retrospective study of patients with mandibular ameloblastoma in order to evaluate recurrent ameloblastoma management. The study included data from 31 patients over a period of 10 years. Data collected included age, gender, tumor location, histological findings, initial treatment, number of recurrences and year of onset, type of treatment of recurrence, reconstruction and follow-up. Recurrences were detected in nine patients (29%). Tumor recurrences appeared at 32 months on average following the initial surgical procedure. Recurrences were associated mainly to inadequate initial therapeutic approach and were treated by bone resection with a safety margin of at least 1 cm beyond the radiographically visible margins. Immediate reconstruction of bone defects was performed with grafts or free flaps.

• Authors: Pedro Infante-Cossio, Victoria Prats-Golczer, Luis-Miguel Gonzalez-Perez, Rodolfo Belmonte-Caro, Rafael Martinez-DE-Fuentes, Eusebio Torres-Carranza, Purificacion Gacto-Sanchez, Tomas Gomez-Cia
• Journal: Experimental and therapeutic medicine (Exp Ther Med) Vol. 6 Issue 2 Pg. 579-583 (Aug 2013) ISSN: 1792-0981 [Print] Greece
• PMID: 24137230 (Publication Type: Journal Article)